BARCELONA, Spain I March 13, 2025 I SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations ...

OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, has been honoured with a spot on the Financial Times’ prestigious ‘UK Best Employers 2025’ list. This recognition ...

AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company today announces the publication of two abstracts submitted to The Association for Research in Vision and Ophthalmology Annual ...

PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...

The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...

Bio-Rad Laboratories, Inc has introduced Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

ProBioGen has expanded its protein and viral vector manufacturing capabilities at its Berlin headquarters, reinforcing its ...

Meiragtx's AAV-GAD program for Parkinson's disease is phase 3 ready, with positive data from a randomized, sham-controlled ...

AskBio has dosed the first participant in the second group of a Phase 1/2 trial of AB-1003, an experimental gene therapy for ...